MHRA Process for Approving Manufacturing Authorizations or API Registrations in Relation to Unlicensed Cannabis-Based Products for Medicinal Use (CBPMs)

16 November 2022 – MHRA Inspectorate published the blog on MHRA process for approving unlicensed CBPMs.

Several companies have contacted the MHRA regarding cannabis-based products for medicinal use. This blog provides information on what authorizations are required in order to manufacture within this sector of the pharmaceutical industry.

Read more online 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /